Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 1/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | CNR1 | P21554 | 1/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 1/20 | 1.00 |
| ▸ | AGTR1 | P30556 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 1/20 | 1.00 |
| ▸ | OPRK1 | P41145 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sofalcone SCHEMBL30383975 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL25214686 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL24786 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL29363342 | 1.00 | MAPT (1.00) | MAPTMEN1KMT2ANR1I2LMNA | |
| SCHEMBL9364195 | 0.99 | MAPT (0.98) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL7842101 | 0.99 | MAPT (0.98) | MAPTMEN1KMT2ANR1I2LMNA | |
| SCHEMBL9364183 | 0.99 | MAPT (0.98) | MAPTMEN1KMT2ANR1I2LMNA | |
| SCHEMBL30382974 | 0.99 | MAPT (0.98) | MAPTMEN1KMT2ANR1I2LMNA | |
| Sofalcone SCHEMBL10888696 | 0.96 | MAPT (0.92) | MAPTMEN1KMT2ANR1I2LMNA | |
| SCHEMBL9368121 | 0.94 | MAPT (0.89) | MAPTMEN1KMT2ANR1I2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | claimed |
| WO-2025264604-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | claimed |
| EP-4580612-A1 | USE OF NRF2 ACTIVATORS FOR THE TREATMENT OF CEREBRAL SMALL VESSEL DISEASE | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-07-09 | — | — | EP | claimed |
| US-20250090565-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YewSavin, Inc. (US) | 2025-03-20 | — | — | US | claimed |
| CN-118235758-B | Adipose-derived mesenchymal stem cell cryopreservation liquid and application thereof | 吉林省微渺医疗科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-113995723-B | Preparation method of sofalcel freeze-dried powder injection and product and application thereof | 浙江普洛家园药业有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | claimed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | claimed |
| CN-118235758-A | Adipose-derived mesenchymal stem cell cryopreservation liquid and application thereof | 吉林省微渺医疗科技有限公司 | 2024-06-25 | — | — | CN | claimed |
| US-6103765-A | Methods for treating male erectile dysfunction | ANDROSOLUTIONS, INC. (US) | 2000-08-15 | — | — | US | claimed |
| EP-1005336-A1 | IMPROVED METHODS AND COMPOSITIONS FOR TREATING MALE ERECTILE DYSFUNCTION | Androsolutions, Inc. (US) | 2000-06-07 | — | — | EP | claimed |
| US-5908824-A | DISPERSED HOMOGENEOUSLY IN AND ADSORBED HOMOGENEOUSLY ONTO A MUCOSA PROTECTING AND/OR TISSUE REPAIRING AGENT | DOTT RESEARCH LABORATORY (JP) | 1999-06-01 | — | — | US | claimed |
| WO-1999002147-A1 | IMPROVED METHODS AND COMPOSITIONS FOR TREATING MALE ERECTILE DYSFUNCTION | ANDROSOLUTIONS, INC. (US) | 1999-01-21 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |
| EP-0770390-A1 | Nasally administrable compositions containing physiologically active peptides | DOTT RESEARCH LABORATORY (JP) | 1997-05-02 | — | — | EP | claimed |
| US-5457128-A | Topical preparation for healing wounds of the skin | DOTT LIMITED COMPANY (JP) | 1995-10-10 | — | — | US | claimed |
| EP-0591546-A1 | EXTERNAL PREPARATION FOR CURING DAMAGE TO SKIN | DOTT LIMITED COMPANY (JP) | 1994-04-13 | — | — | EP | claimed |
| US-4085135-A | ANTIULCER | TAISHO PHARMACEUTICAL CO., LTD. (JA) | 1978-04-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MAPT 3297/4885MEN1 3367/4885KMT2A 2792/4885 |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | SQSTM1, BECN1, CUTA | MAPT 411/4885MEN1 3254/4885KMT2A 3682/4885 |
| US-20250090565-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, TFPI, SERPINE1 | MAPT 3522/4885MEN1 2669/4885KMT2A 3216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.